Nanobody-enabled structural and functional studies of Chemokine-CCR5 active-state complexes

Medicine & Life Sciences

1. Chemokine Receptors 100%
2. Chemokines 61%
3. Ligands 31%
4. Scavenger Receptors 29%
5. Opioid Peptides 21%
6. Opioid Receptors 19%
7. CC Chemokines 19%
8. G-Protein-Coupled Receptors 17%
9. Arrestin 16%
10. CXC Chemokines 15%
11. Adrenomedullin 14%
12. Maraviroc 13%
13. Artificial Receptors 13%
14. Single-Domain Antibodies 13%
15. Cannabinoid Receptor Agonists 12%
16. Neoplasms 11%
17. Opioid Analgesics 10%
18. Epithelial-Mesenchymal Transition 10%
19. Chemokine CXCL10 9%
20. Music 9%
21. Disulfides 9%
22. Bacteriophages 8%
23. Autophagy 8%
24. Peptides 8%
25. Natural Killer Cells 8%
26. Liver Diseases 7%
27. Melanoma 7%
28. Molecular Biology 7%
29. Pathologic Processes 7%
30. Signal Transduction 6%
31. Fibroblasts 6%
32. Chronic Disease 6%
33. Stem Cells 6%
34. Neoplasm Metastasis 6%
35. Macrophages 6%
36. GTP-Binding Proteins 6%
37. Breast Neoplasms 5%
38. Cannabinoid Receptors 5%
39. CXCR4 Receptors 5%
40. BAM22 peptide 5%
41. Chemokine CXCL11 5%
42. Therapeutics 5%
43. Cell Movement 5%
44. Cannabinoids 5%
45. Chemotaxis 5%
46. N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide 5%